FCGR3A and neoplasm: Consequently, innate cell engagers link tumor antigens, such as EGFR, to FcγRIIIa (CD16A) on NK cells or macrophages and activate ADCC and ADCP, resulting in tumor cell killing and phagocytosis of tumor cells, respectively (209), and potentially the reduction of a tumor mass.